The ICH Q9 Training package - What is behind it? - Live Online Training

The first revision of the ICH Q9 guideline on risk management has provided further clarification on Quality Risk Management (QRM). Topics specifically addressed by the revision are subjectivity, formality and risk-based decision-making in QRM. In addition, the revision clarifies why the risk management process starts with hazard identification rather than risk identification, and how QRM can support medicinal product availability. The ICH Q9(R1) training package provides in-depth information on all these topics, and has an additional chapter on risk review. The aim of the event is to give you a compact overview of the 9 slide sets with over 300 slides of the ICH Q9(R1) training package.

 

Addressed are:

As a member of the Expert Working Group (EWG), the speaker is a co-author of the ICH Q9(R1) Guideline.

Since 2005, the ICH Q9 guideline has been the state of the art when it comes to quality risk management. It found its way into the EU GMP guidelines, initially as Annex 20 and was then incorporated into Part III, where it is still to be found today. In addition, an ICH Q9 briefing package was also developed and then made available on the ICH website. This briefing package was intended to clarify the Guideline.

 

At the end of 2020, the ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) announced that it would revise the ICH Q9 guideline. After several years of work, the final revision was released as “R1” at the beginning of 2023. Changes were mainly made in four areas

In addition, training material on risk review and hazard identification as the first step in QRM has been produced. Detailed training material on all these areas was published in October 2023; it consists of nine files totaling over 300 slides and some case studies.